Swan Corp growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
−11.5%−1.6%+248.9%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−44.2%−116.3%+275.4%
−13.5%−138.3%+402.5%
−69.0%+49.2%+1,059.8%
−70.0%+40.2%+916.3%
+1.8%+11.8%+19.0%
+3.1%+11.2%+114.8%
+97.3%−2,144.4%+105.3%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SWANCORP₹242.25

Swan Corp Ltd.

· Chemicals
₹ CrorePeersANURASATULSHKBAYERCROPCAMLINFINEDEEPAKFERTCLEANCHAMBLFERTMcap ₹7,593 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—+248.9-1.6-11.5—
EBITDA Growth—+275.4-116.3-44.2—
EBIT Growth—+402.5-138.3-13.5—
Net Income Growth—+1,059.8+49.2-69.0—
EPS Growth—+916.3+40.2-70.0—
Total Assets Growth—+19.0+11.8+1.8—
Total Equity Growth—+114.8+11.2+3.1—
Cash from Operations Growth—+105.3-2,144.4+97.3—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.